There is evidence to suggest that the symptoms of a severe shock seen in fatal gas gangrene in man caused by Cl. welchii type A cannot be attributed entirely to poisoning by Cl. welchii alpha toxin.
tJ~7 OCT 1970 Animal Experiments and the Etiology of Gas Gangrene There is evidence to suggest that the symptoms of a severe shock seen in fatal gas gangrene in man caused by Cl. welchii type A cannot be attributed entirely to poisoning by Cl. welchii alpha toxin. To investigate this problem animal experiments are essential. It has been found that fatal infections with Cl. welchii type A can be produced in guinea-pigs passively immunized with very large amounts of alpha antitoxin. In these circumstances it is highly unlikely that alpha toxin plays any part in the production of shock. A possible explanation is the remarkable ability of Cl. welchii to remove oxygen from its environment with a correspondingly rapid fall in the oxidationreduction potential (Eh) of the tissue. We have evidence to suggest that the severe local anoxia produced by this organism can cause a rapid increase in vascular permeability which leads to severe hvmoconcentration and shock.
It seems quite possible that a phenomenon of this kind could account for the failure of antitoxin to prevent fatal shock in severe cases of gas gangrene in man.
Dr F T Perkins (National Institutefor Medical Research, Holly Hill, London NW3)
The Use of Standardized Cell Substrates as an Alternative to Primary Animal Tissue for Vaccine Production When we look at the enormous developments that have taken place in virus vaccine production it is surprising that so little attention has been given to the standardization of the cell substrate. There is a wealth of information on the growth requirements of different cell cultures and much has been done to obtain reproducibility between batches of calf serum. The virus used for vaccine production is selected with the utmost caution requiring carefully controlled clinical trials to ensure that it is both safe and immunogenic. Indeed the virus seed pool used as the starting point for the production of each batch of vaccine is thoroughly checked to ensure its freedom from extraneous agents and untoward characteristics. Finally, each batch of vaccine undergoes the most stringent tests to ensure its safety. It seems logical to suggest that just as much care and attention should be given to the selection, testing and standardization of the cell substrate used for the propagation of the virus to be incorporated in the vaccine.
What are the alternatives to primary monkey kidney tissue? Several have been suggested: Earle's mouse L cells, continuous monkey kidney cells and even chick embryo fibroblast cell lines. In making a choice several conditions must be satisfied: (1) The cell must remain normal throughout life. (2) It should be embryonic tissue since these are the least likely to be inherently contaminated.
(3) It should be tissue from a nondifferentiating organ. (4) It must be a tissue undergoing a sufficient number of cell doublings to provide an economic source of tissue to the manufacturer. (5) It should be a tissue susceptible to most human viruses. Such a cell line was started by Professor L Hayflick and Dr P Moorhead when they established a population of human embryo lung fibroblast cells. One such cell line is known as WI-38. Many laboratories have examined this tissue and none has found a contaminating virus, whereas all have found the cells to remain normal throughout 30 to 35 cell doublings. We have learnt a great deal about the practical limits of handling such
